Related references
Note: Only part of the references are listed.Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
Tamara Aleksic et al.
CANCER RESEARCH (2010)
Sex Steroids Upregulate the IGF-1R in Prostate Cancer Cells through a Nongenotropic Pathway
Giuseppe Pandini et al.
STEROID ENZYMES AND CANCER (2009)
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer
John S. P. Yuen et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer
Teresa Chiaverotti et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium
Brent W. Sutherland et al.
CANCER RESEARCH (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis
Shintaro Narita et al.
PROSTATE (2008)
Differential localization of MT1-MMP in human prostate cancer tissue: Role of IGF-1R in MT1-MMP expression
Isis C. Sroka et al.
PROSTATE (2008)
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer
Stephen R. Plymate et al.
CLINICAL CANCER RESEARCH (2007)
Origin of androgen-insensitive poorly differentiated tumors in the Transgenic adenocarcinoma of mouse prostate model
Wendy J. Huss et al.
NEOPLASIA (2007)
The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma
J. S. P. Yuen et al.
ONCOGENE (2007)
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline
D. Andrew Loblaw et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Effective chemotherapy for hormone-refractory prostate cancer (HRPC): Present status and perspectives with taxane-based treatments
Andrea Mancuso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs
A. H. Yeh et al.
ONCOGENE (2006)
Interaction of IGF signaling and the androgen receptor in prostate cancer progression
Jennifer D. Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization
D Gioeli et al.
MOLECULAR ENDOCRINOLOGY (2006)
Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade
YD Liao et al.
HUMAN PATHOLOGY (2005)
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells
G Pandini et al.
CANCER RESEARCH (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells
H Zhao et al.
ONCOGENE (2004)
Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors
M Goya et al.
CANCER RESEARCH (2004)
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model
SL Krueckl et al.
CANCER RESEARCH (2004)
Blockade of the type IIGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates lGF binding protein-3, and suppresses MMP-2 expression
M Grzmil et al.
JOURNAL OF PATHOLOGY (2004)
Pathologic T1 clear cell renal cell carcinoma: Insulin-like growth factor-I receptor expression and disease-specific survival
AS Parker et al.
CANCER (2004)
Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-1 on proliferation and AR activity between localized and metastatic tumors
SR Plymate et al.
PROSTATE (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis
J Rubin et al.
PROSTATE (2004)
IGF-I and MAP kinase involvement in the stimulatory effects of LNCaP prostate cancer cell conditioned media on cell proliferation and protein synthesis in MC3T3-E1 osteoblastic cells
RS Bhattacharyya et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript
EA Bohula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor
GO Hellawell et al.
BJU INTERNATIONAL (2003)
High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas
AS Parker et al.
HUMAN PATHOLOGY (2002)
Insulin-like growth factor-I and prostate cancer: a meta-analysis
R Shi et al.
BRITISH JOURNAL OF CANCER (2001)
Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase
VM Macaulay et al.
ONCOGENE (2001)
Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells
SE Damon et al.
ENDOCRINOLOGY (2001)
Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: Correlation with clinico-pathological parameters
JA Figueroa et al.
CANCER INVESTIGATION (2001)
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk:: a prospective study
P Stattin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer
SM Harman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen
P Finne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation
K Reiss et al.
ONCOGENE (2000)
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice
J DiGiovanni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
